TIMAXTRU
LIVE

Serial Number

79402258

Owner

Boehringer Ingelheim International GmbH

Filing Date

Jul 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TIMAXTRU Trademark

Serial Number: 79402258 • Registration: 7718011

TIMAXTRU is a trademark filed by Boehringer Ingelheim International GmbH on July 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Boehringer Ingelheim International GmbH (4 trademarks)

Binger Strasse 173
Ingelheim 55218 , DE

Entity Type: 03

Trademark Details

Filing Date

July 5, 2024

Registration Date

March 11, 2025

Published for Opposition

January 21, 2025

Goods & Services

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 29, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 14, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 14, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 10, 2025 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 11, 2025 R.PR
PUBLISHED FOR OPPOSITION
Jan 21, 2025 PUBO
NOTICE OF PUBLICATION
Jan 15, 2025 NPUB
WITHDRAWN FROM ISSUE - OG REVIEW QUERY
Jan 10, 2025 ISCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 29, 2024 CNSA
ASSIGNED TO EXAMINER
Dec 28, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 1, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 1, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 29, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 15, 2024 REPR